Multi-Service Clearance: The New Metric for Cardiac AI Value
The standard 10-year horizon for cardiac risk models is fine for assessing broad populations, but it’s old news. What if you could get a warning…
The standard 10-year horizon for cardiac risk models is fine for assessing broad populations, but it’s old news. What if you could get a warning…
Going public completely changes how a company’s evidence trail is seen. Information that used to be locked away in private diligence or handed out selectively…
The path to innovation in healthcare AI is not always linear. Sometimes, a cleared trail and promising initial results still lead to an unexpected end.…
The promise of AI in healthcare often arrives with compelling cost-savings projections, but these claims are only as strong as the underlying engagement record. For…
See how 2026's top AI health companies use AI for patient outcomes. Learn what makes them succeed and why it matters for healthcare's future.
Traditional heart risk assessments miss early threats. Learn how Hello Heart's 10-day warning can prevent 30% of major cardiac events.
A Fast Company award for an AI health company in 2026 signals key trends. Understand what makes these firms leaders and how they achieve patient privacy.
Struggling to get health press coverage? Learn 5 steps to reach a wider audience and educate more people about your unique health philosophy.
Stop losing grants to misinformation. Learn how to align applications with funder priorities and secure funding for your health initiatives, even as a small
Hello Heart's 10-day warning identifies immediate heart risks, saving lives and reducing emergency costs. See how it beats 10-year models.